Michael Wakelam

{{Short description|British scientist (1955–2020)}}

{{More citations needed|date=April 2020}}

{{Use dmy dates|date=February 2018}}

{{Use British English|date=February 2018}}

{{Infobox scientist

| name = Michael Wakelam

| birth_date = {{birth date |1955|7|15|df=yes}}

| birth_place =

| death_date = {{death date and age |2020|3|31|1955|7|15|df=yes}}

| death_place =

| nationality = British

| education = University of Birmingham

| field = biochemistry, lipidomics, signal transduction

| workplaces = University of Konstanz, Imperial College London, University of Glasgow, University of Birmingham, Babraham Institute

}}

Michael John Owen Wakelam (15 July 1955 – 31 March 2020) was a British molecular biologist and director of the Babraham Institute in Cambridge, England.

Biography

Wakelam received a BSc in medical biochemistry (1977) and a PhD in biochemistry (1980) from the University of Birmingham. After post-doctoral training at the University of Konstanz (DE), he joined the Department of Biochemistry of Imperial College London in 1983. In 1985, he joined the Biochemistry department of the University of Glasgow as a Lecturer (1985), Senior Lecturer (1991) and Reader (1992). He became a Professor of molecular pharmacology at the University of Birmingham in 1993. In 2007, he became director of the Babraham Institute in Cambridge.{{Cite web|url=https://www.babraham.ac.uk/news/2020/04/michael-wakelam-1955-2020|title=Michael Wakelam 1955 – 2020 | Babraham Institute|website=www.babraham.ac.uk|accessdate=2 April 2020}}

Wakelam died on 31 March 2020, of a suspected COVID-19 infection during the COVID-19 pandemic in England.[https://www.cambridgeindependent.co.uk/news/babraham-institute-director-professor-michael-wakelam-dies-after-suspected-coronavirus-infection-9105113/ Babraham Institute director Professor Michael Wakelam dies after suspected coronavirus infection]

References

{{Reflist}}